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Atrial fibrillation is present in approximately 50% of all patientsundergoing surgery for the treatment of mitral valve disease.1-3For more than 40 years, cardiac surgeons have been forced toignore this associated atrial fibrillation at the time of open mitralvalve surgery because there has been no effective way to treat it.After the success of the maze procedure in treating atrial fibrilla-
tion,4-6 several surgeons began to add the maze procedure as an adjunct to mitral
valve surgery to treat both problems.7-9 When properly performed, the results with
this combined approach have been excellent, with no increase in perioperative mor-
bidity or operative mortality and with documented long-term advantages over sim-
ply leaving patients in atrial fibrillation.8,9 Despite these results, adding the maze
procedure to mitral valve surgery significantly prolongs and complicates the opera-
tion; therefore, most surgeons have understandably been reluctant to perform the
combined procedure.
During the past 2 to 3 years, cardiologists have become extremely aggressive in
their efforts to treat atrial fibrillation by modifications of the percutaneous radiofre-
quency catheters that have been so successful in treating other types of arrhythmias,
especially the Wolff-Parkinson-White syndrome.10-13 It was only a matter of time
until some surgeons used these same percutaneous endocardial catheters to treat
atrial fibrillation intraoperatively when performing mitral valve surgery. This new
surgical intervention was quickly recognized by medical device companies as a new
market and, as a result, new radiofrequency devices have been adapted specifically
for intraoperative use.
In this issue of the Journal, the group from Maastricht, The Netherlands,
describes the use of intraoperative radiofrequency catheters to ablate atrial fibrilla-
tion in patients who required surgery primarily for mitral valve disease. This study
is particularly important because it comes from perhaps the premier electrophysiol-
ogy group in the world, especially in the area of atrial fibrillation. Clinical electro-
physiology was born in the laboratory of Professor Dirk Durrer of Amsterdam and
led to his becoming the first to perform an intraoperative electrophysiologic map of
the human heart in 1957. In 1967, Dr Durrer’s brilliant protégé, Professor Hein J. J.
Wellens, one of the authors of this article, described the technique of programmed
electrical stimulation that provided a method for reproducibly inducing and termi-
nating reentrant arrhythmias. This landmark achievement made possible the sys-
tematic characterization of most clinical arrhythmias and has remained largely
unchanged since that time. Thus, it behooves us all to listen when this group speaks
of electrophysiology matters!
The authors describe their experience with the use of intraoperative radiofre-
quency catheters to create linear lesions in both atria in an effort to ablate atrial fib-
rillation associated with other surgical heart disease in 122 patients, 108 of whom
had associated mitral valve surgery. The pattern of lesions placed in the atria was
described as “a modification of the maze III procedure.” Actuarial freedom from
atrial flutter or atrial fibrillation at 39 months was 78.5% ± 5.1%.
These results are consistent with those obtained by Melo’s group in Portugal,14
Mohr’s group in Leipzig, Germany,15 and Alfieri’s group in Italy,16 all of whom also
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use radiofrequency energy to create the lesions in the atria.
Similar results have also been attained by Stephan Schuler
in Dresden, Germany,17 using microwave energy to create
the atrial lesions. However, these studies raise an important
question. Why are 20% to 30% of the patients not cured of
their atrial fibrillation? Assuming that an 80% cure rate is
not acceptable to most cardiac surgeons, we are obligated to
answer that question.
During the past several years, at least two major obser-
vations regarding atrial fibrillation have had a direct impact
on these new intraoperative techniques to treat atrial fibril-
lation associated with mitral valve disease. The first is that
the maze procedure, when properly performed, cures atrial
fibrillation in nearly 100% of patients with or without mitral
valve disease.4-6 The second is that the majority of paroxys-
mal (intermittent) atrial fibrillation originates within the ori-
fices of one or more of the pulmonary veins.18 Thus, to my
knowledge, all of the techniques now being used to treat
atrial fibrillation during mitral valve surgery incorporate
some combination of the linear lesions of the maze proce-
dure with isolation of one or more of the pulmonary vein
orifices. Unfortunately, the scientific basis for these various
approaches is somewhat less than completely sound.
A cardinal rule of scientific experimentation is that all
variables in an experiment must be controlled except the one
variable that is being studied. Thus, when attempting to
modify a successful operative procedure, one should avoid
introducing more than one variable if the final results of the
modification are to be subject to scientific interpretation.
Unfortunately, these recent attempts to ablate atrial fibrilla-
tion at the time of mitral valve surgery have violated that
principle, because multiple variables have been introduced
simultaneously, thereby precluding our ability to identify
the reason for the 20% failure rate. For example, the fol-
lowing combinations of variables are currently in the mix of
intraoperative approaches to the treatment of atrial fibrilla-
tion during mitral valve surgery.
1. Different energy sources to create atrial lesions: These
include radiofrequency energy, microwave energy,
laser energy cryosurgery, and the cut-and-sew tech-
nique.
2. Different locations of the atrial lesions: These include
“left-sided mazes,” “right-sided mazes,” pulmonary
vein encirclement only, and the connection of various
pulmonary vein orifices in various combinations with
or without a contiguous lesion down to the mitral
valve anulus, ignoring the importance of the coronary
sinus in postoperative atrial flutter and fibrillation.
Energy Source
The basis of all arrhythmia surgery since Dr Sealy’s first
operation for the Wolff-Parkinson-White syndrome in
196819 is that the fibrocytes that make up scar tissue will not
conduct electricity. Indeed, fibrocytes may well be the most
effective insulators against electrical conduction in all of
nature, since a single cell layer of fibrocytes will block elec-
trical conduction in the heart permanently. For a line of
complete conduction block to be created, however, a lesion
placed in the atrial wall must be transmural or else electri-
cal activity can traverse the line of the lesion.20 For exam-
ple, if a linear radiofrequency lesion is placed on the endo-
cardial side of the atrium and is not transmural, electrical
activity can traverse the line of the lesion on its epicardial
side. Conversely, if a linear lesion is placed on the epicardial
side of the atrium and is not transmural, electrical activity
can traverse the line of the lesion on its endocardial side.
When the maze procedure was originally developed, we
chose to use the cut-and-sew technique exclusively for one
simple reason: We could be absolutely certain that each and
every atrial lesion was transmural because we could see that
it was. We then placed a cryolesion at any site where there
might be microscopic connections remaining that could not
be seen and that might allow electrical conduction to
“bridge” the otherwise transmural atrial lesion. These sites
included the ends of two right atriotomies that terminated at
the tricuspid valve anulus, one left atriotomy that terminat-
ed at the mitral valve anulus, and the coronary sinus that
itself bridges one of the posterior left atriotomies. By using
this technique exclusively, we could be certain that if the
operation ultimately failed, it would do so because it was
based on a faulty concept, not because it had been per-
formed incorrectly or incompletely.
When we had to make the first modification of the maze
procedure (from the maze I to the maze II procedure),21,22
the only variable that was introduced was a slight change in
the precise pattern of the atrial lesions. The basic cut-and-
sew technique was left unchanged. Again, when we made
the second modification (from the maze II to the maze III
procedure),21,22 we still were careful to introduce only one
variable, a change in the pattern of the atriotomies, with the
modification. As a result, the efficacy of the maze procedure
in curing atrial fibrillation remained unchanged from the
maze I to the maze II to the maze III, but the undesirable
side-effects of the first two procedures were eliminated by
these modifications.
The major problem with using radiofrequency,
microwave, or laser energy to treat atrial fibrillation is that
there is no way to document with certainty that a lesion is
transmural at the time it is created. Studies have been per-
formed to relate the depth of a lesion to the energy expend-
ed, time of application, and temperature of the probe tip,23-25
but the fact remains that there is simply no real-time method
of being certain that a given lesion is transmural using these
energy sources.
What, then, are the alternatives to creating the lesions
with the old cut-and-sew technique that allow for real-
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time documentation of the transmurality of the linear
lesions? We now use cryosurgery for the creation of these
linear lesions,9 rather than the cut-and-sew technique,
because the surgeon simply has to look at the cryolesion
to see when it has become transmural. Once the ice ball
has become transmural, the cryoprobe is held in place for
120 seconds and then defrosted. The certainty of perma-
nent transmurality with this method is based on scientific
and clinical studies dating back over 25 years to when
cryosurgery was first used intraoperatively to treat cardiac
arrhythmias.26-28 In fact, we now perform the entire maze
procedure using linear cryoprobes, rather than the cut-
and-sew technique, whether or not it is performed in com-
bination with mitral valve surgery.
Pattern of Atrial Lesions
The recent demonstration by Haissaguerre and associates18
that the majority of atrial fibrillation originates within the
pulmonary veins was at once a magnificent revelation for
basic electrophysiologists and a treacherous trap for unsus-
pecting interventional electrophysiologists and arrhythmia
surgeons. This important contribution to the understanding
of atrial fibrillation does not represent the holy grail for
treatment purposes, but rather it is the remaining piece of
the previously incomplete puzzle of atrial fibrillation. It fits
with the other pieces in the following manner.
Under normal circumstances, the atria are activated by
the sinus node, remain in sinus rhythm, and are extremely
resistant to the development of atrial fibrillation, as evi-
denced by the fact that less than 2% of the general popula-
tion is in atrial fibrillation.29 Because there is a transition
zone between the endothelium of the pulmonary veins and
the endocardium of the left atrium, this is the proper milieu
for the development of MICRO-reentry circuits that can
lead to premature atrial beats. These premature atrial beats,
in turn, can stimulate the atria in such a manner that
MACRO-reentrant circuits are set up in the atria that
become self-perpetuating. This is atrial fibrillation.30 In
other words, the atrial fibrillation is initiated by micro-reen-
trant circuits within the pulmonary veins and is sustained by
macro-reentrant circuits in the atrial myocardium itself.
Usually, the atria retain their natural tendency to remain
in a normal rhythm, so they will eventually spontaneously
revert to a normal sinus rhythm. Later, the micro-reentry cir-
cuits in the pulmonary veins reinduce atrial fibrillation, and
we recognize the clinical picture of paroxysmal (intermit-
tent) atrial fibrillation. This type of atrial fibrillation can be
cured by one of the following techniques:
1. Identifying the culprit pulmonary vein and ablating
the micro-reentrant circuit within its orifice
This is the basis for the percutaneous endocardial
catheter mapping followed by map-guided radiofre-
quency ablation within a single pulmonary vein ori-
fice that is now performed by interventional electro-
physiologists.
2. Identifying the culprit pulmonary vein and isolating
its orifice from the remainder of the atrial myocardi-
um
This also involves catheter mapping by interven-
tional electrophysiologists but is followed by attempts
at placing circumferential rings of block around the
orifice of the culprit pulmonary vein using either
radiofrequency, cryothermia, ultrasound, microwave,
or laser energy sources.
3. Isolating the orifices of all four pulmonary veins from
the remainder of the atrial myocardium
This is the most logical way for surgeons to treat
this type of atrial fibrillation during mitral valve
surgery because there is currently no way of identify-
ing the culprit pulmonary vein intraoperatively.
Unfortunately, as the atrium begins to fibrillate more and
more, it undergoes a process that has been described as
“atrial remodeling” by Professor Maurits Allessie,31 one of
Professor Wellens’ brilliant colleagues in Maastricht.
Allessie describes the results of this electrophysiologic (and
perhaps anatomic) remodeling as “atrial fibrillation begets
atrial fibrillation.” In other words, the more the atrium fib-
rillates, the more it is inclined to fibrillate. Finally, in most
patients, the paroxysmal atrial fibrillation evolves into
chronic (continuous) atrial fibrillation because of this
process of atrial remodeling.
From the treatment standpoint, it is critical to understand
that once this has occurred, the pulmonary veins, and the
latent or active micro-reentrant circuits that they may har-
bor, become irrelevant to the maintenance of the atrial fib-
rillation. In other words, not even complete isolation of all
four pulmonary veins will ablate the atrial fibrillation at this
point, and certainly anything less than their complete isola-
tion cannot be expected to be effective. Indeed, the only
known nonpharmacologic way to stop the atrial fibrillation
at this point is to render the atria incapable of harboring the
macro-reentrant circuits that are the basis of atrial fibrilla-
tion once it is established. This is what the maze procedure
does. Unfortunately, no other pattern of atrial lesions has yet
been described to accomplish this goal.
In summary, the attempts at ablating atrial fibrillation
during mitral valve surgery using multiple energy sources
that are easy to handle and quick to apply is to be strongly
encouraged. However, surgeons should make every effort to
assure that the lesions they create are transmural in every
instance, or else the operation is doomed to a high rate of
failure.20 Furthermore, until a less complex pattern of atrial
lesions has been shown to be as effective as the maze pro-
cedure, I believe that the pattern of lesions applied during
surgery should conform exactly, or nearly so, to the pattern
of the maze procedure. With minor modifications, the maze
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procedure can now be performed with the use of linear cryo-
probes to assure transmurality without substantially increas-
ing either the complexity or the duration of mitral valve
surgery and with the expectation that 99% of the atrial fib-
rillation associated with the mitral valve disease will be
cured. That should be the goal of any other energy source
and of any other pattern of atrial lesions.
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